{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:03:17Z","timestamp":1780092197941,"version":"3.54.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":276,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005897","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e9 Paris Cit\u00e9"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:p>CD39, an ectoenzyme in the immunosuppressive CD39\/CD73\/adenosine pathway, known to promote solid tumour outgrowth and spreading, was investigated in both skin and blood compartments of cutaneous T cell lymphomas. CD39 was overexpressed by peripheral blood T-cells in Sezary syndrome and mycosis fungoides, and in skin-infiltrating lymphocytes of Sezary syndrome, mycosis fungoides, subcutaneous panniculitis-like T-cell lymphoma and primary cutaneous CD30-positive lymphoproliferation. Our study emphasizes the interest in using CD39\/CD73\/adenosine pathway blocking agents for cutaneous T cell lymphomas treatment.<\/jats:p>","DOI":"10.1002\/ski2.334","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T05:03:37Z","timestamp":1704863017000},"source":"Crossref","is-referenced-by-count":4,"title":["CD39 is Expressed by a Wide Range of Cutaneous T-Cell Lymphomas"],"prefix":"10.1093","volume":"4","author":[{"given":"Gilles","family":"Battesti","sequence":"first","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Thonnart","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliz\u00e9e","family":"Bozonnat","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ram-Wolff","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]},{"name":"Department of Dermatology, Saint-Louis Hospital , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"de Masson","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]},{"name":"Department of Dermatology, Saint-Louis Hospital , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Bensussan","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]},{"name":"Department of Dermatology, Saint-Louis Hospital , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Marie-Cardine","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Battistella","sequence":"additional","affiliation":[{"name":"Team 1, Human Immunology, Pathophysiology, Immunotherapy, INSERM U976 , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, IRSL , Paris ,","place":["France"]},{"name":"Department of Pathology, Saint-Louis Hospital , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"issue":"5","key":"2025112605115913200_ski2334-bib-0001","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2021","journal-title":"Blood"},{"issue":"15","key":"2025112605115913200_ski2334-bib-0002","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158068","article-title":"CD39 regulation and functions in T cells","volume":"22","author":"Timperi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2025112605115913200_ski2334-bib-0003","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep"},{"issue":"6","key":"2025112605115913200_ski2334-bib-0004","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14737140.2017.1316197","article-title":"Targeting adenosine in cancer immunotherapy: a review of recent progress","volume":"17","author":"Whiteside","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"2025112605115913200_ski2334-bib-0005","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jid.2018.09.026","article-title":"Identification of CD39 as a marker for the circulating malignant T-cell clone of S\u00e9zary syndrome patients","volume":"139","author":"Bensussan","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"17","key":"2025112605115913200_ski2334-bib-0006","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1182\/blood.2021014782","article-title":"Involvement of the CD39\/CD73\/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in S\u00e9zary syndrome","volume":"139","author":"Sonigo","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025112605115913200_ski2334-bib-0007","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1182\/blood.2022017259","article-title":"CD39\/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with S\u00e9zary syndrome","volume":"141","author":"Yakymiv","year":"2023","journal-title":"Blood"},{"issue":"11","key":"2025112605115913200_ski2334-bib-0008","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1016\/j.jid.2022.04.017","article-title":"Genetically driven CD39 expression affects Sezary cell viability and IL-2 production and detects two patient subsets with distinct prognosis","volume":"142","author":"Picozza","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"5","key":"2025112605115913200_ski2334-bib-0009","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2025112605115913200_ski2334-bib-0010","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1182\/blood-2017-03-772996","article-title":"Circulating and skin-derived S\u00e9zary cells: clonal but with phenotypic plasticity","volume":"130","author":"Roelens","year":"2017","journal-title":"Blood"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/2\/ski2.334\/59729914\/skinhd_4_2_e334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/2\/ski2.334\/59729914\/skinhd_4_2_e334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:12:05Z","timestamp":1764151925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.334\/7736674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,10]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.334","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,10]]},"article-number":"ski2.334"}}